Skip to main content
Log in

What drives operational performance in clinical R&D?

  • From the Analyst's Couch
  • Published:

From Nature Reviews Drug Discovery

View current issue Sign up to alerts

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1: Variation in performance among 14 companies.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Michael Ringel or Linda Martin.

Ethics declarations

Competing interests

The authors are employees of The Boston Consulting Group (BCG) and KMR Group, two organizations that consult with the world's leading biopharmaceutical companies on clinical R&D activities. The research for this specific article was funded by participating benchmark companies, BCG's health care practice and KMR Group.

PowerPoint slides

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ringel, M., Martin, L., Hawkins, C. et al. What drives operational performance in clinical R&D?. Nat Rev Drug Discov 15, 155–156 (2016). https://doi.org/10.1038/nrd.2016.2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrd.2016.2

  • Springer Nature Limited

Navigation